Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals Price to Sales Ratio 2010-2024 | JAZZ

Historical PS ratio values for Jazz Pharmaceuticals (JAZZ) over the last 10 years. The current P/S ratio for Jazz Pharmaceuticals as of December 17, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Jazz Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-12-17 122.49 2.05
2024-09-30 111.41 $59.87 1.86
2024-06-30 106.73 $56.81 1.88
2024-03-31 120.42 $55.12 2.18
2023-12-31 123.00 $52.80 2.33
2023-09-30 129.44 $54.30 2.38
2023-06-30 123.97 $55.65 2.23
2023-03-31 146.33 $57.34 2.55
2022-12-31 159.31 $58.17 2.74
2022-09-30 133.29 $57.65 2.31
2022-06-30 156.01 $56.34 2.77
2022-03-31 155.67 $54.28 2.87
2021-12-31 127.40 $51.75 2.46
2021-09-30 130.21 $48.50 2.68
2021-06-30 177.64 $45.51 3.90
2021-03-31 164.37 $42.93 3.83
2020-12-31 165.05 $42.08 3.92
2020-09-30 142.59 $40.42 3.53
2020-06-30 110.34 $39.09 2.82
2020-03-31 99.74 $38.33 2.60
2019-12-31 149.28 $37.52 3.98
2019-09-30 128.14 $35.19 3.64
2019-06-30 142.56 $33.42 4.27
2019-03-31 142.95 $32.27 4.43
2018-12-31 123.96 $30.78 4.03
2018-09-30 168.13 $30.12 5.58
2018-06-30 172.30 $29.23 5.89
2018-03-31 150.99 $27.51 5.49
2017-12-31 134.65 $26.38 5.10
2017-09-30 146.25 $25.68 5.70
2017-06-30 155.50 $25.03 6.21
2017-03-31 145.13 $24.76 5.86
2016-12-31 109.03 $23.98 4.55
2016-09-30 121.48 $22.97 5.29
2016-06-30 141.31 $22.31 6.33
2016-03-31 130.55 $21.46 6.08
2015-12-31 140.56 $21.01 6.69
2015-09-30 132.81 $20.84 6.37
2015-06-30 176.07 $20.33 8.66
2015-03-31 172.79 $19.71 8.77
2014-12-31 163.73 $19.02 8.61
2014-09-30 160.56 $17.61 9.12
2014-06-30 147.01 $16.49 8.91
2014-03-31 138.68 $15.20 9.12
2013-12-31 126.56 $14.18 8.93
2013-09-30 91.97 $13.40 6.86
2013-06-30 68.73 $12.51 5.50
2013-03-31 55.91 $11.18 5.00
2012-12-31 53.25 $9.75 5.46
2012-09-30 57.00 $8.48 6.72
2012-06-30 45.01 $7.15 6.29
2012-03-31 48.47 $6.49 7.47
2011-12-31 38.63 $5.84 6.62
2011-09-30 41.50 $5.40 7.68
2011-06-30 33.35 $4.93 6.77
2011-03-31 31.85 $4.68 6.80
2010-12-31 19.68 $4.84 4.06
2010-09-30 10.73 $4.49 2.39
2010-06-30 7.83 $4.70 1.67
2009-12-31 7.88 $4.32 1.82
2009-09-30 8.02 $4.05 1.98
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.438B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.467B 14.08
Vertex Pharmaceuticals (VRTX) United States $119.424B 0.00
Gilead Sciences (GILD) United States $114.476B 20.73
Bristol Myers Squibb (BMY) United States $113.132B 47.68
CSL (CSLLY) Australia $84.940B 0.00
Regeneron Pharmaceuticals (REGN) United States $80.363B 18.29
GSK (GSK) United Kingdom $70.363B 8.14
Argenex SE (ARGX) Netherlands $36.656B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.657B 0.00
BioNTech SE (BNTX) Germany $28.617B 0.00
Illumina (ILMN) United States $22.818B 83.16
Biogen (BIIB) United States $21.862B 9.39
BeiGene (BGNE) Cayman Islands $17.475B 0.00
Moderna (MRNA) United States $16.097B 0.00
Genmab (GMAB) Denmark $13.348B 19.58
Incyte (INCY) United States $13.206B 0.00
Insmed (INSM) United States $12.815B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.580B 29.21
Bio-Techne Corp (TECH) United States $12.027B 46.44
Sarepta Therapeutics (SRPT) United States $11.817B 106.65
Exact Sciences (EXAS) United States $11.336B 0.00
Vaxcyte (PCVX) United States $10.933B 0.00
QIAGEN (QGEN) Netherlands $10.360B 21.31
Exelixis (EXEL) United States $10.004B 22.75
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $8.803B 0.00
Repligen (RGEN) United States $8.763B 114.17
Roivant Sciences (ROIV) United Kingdom $8.619B 0.00
Ascendis Pharma (ASND) Denmark $7.876B 0.00
Revolution Medicines (RVMD) United States $7.572B 0.00
Legend Biotech (LEGN) United States $6.414B 0.00
Nuvalent (NUVL) United States $6.172B 0.00
Halozyme Therapeutics (HALO) United States $6.107B 13.79
Blueprint Medicines (BPMC) United States $5.920B 0.00
Cytokinetics (CYTK) United States $5.741B 0.00
Telix Pharmaceuticals (TLX) Australia $5.275B 0.00
Viking Therapeutics (VKTX) United States $5.241B 0.00
TG Therapeutics (TGTX) United States $4.984B 0.00
Alkermes (ALKS) Ireland $4.937B 16.58
Krystal Biotech (KRYS) United States $4.706B 77.92
Arcellx (ACLX) United States $4.531B 0.00
ADMA Biologics Inc (ADMA) United States $4.394B 46.47
Axsome Therapeutics (AXSM) United States $4.366B 0.00
Guardant Health (GH) United States $4.295B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.228B 0.00
Apellis Pharmaceuticals (APLS) United States $4.129B 0.00
Scholar Rock Holding (SRRK) United States $3.930B 0.00
Biohaven (BHVN) United States $3.890B 0.00
Avidity Biosciences (RNA) United States $3.876B 0.00
Immunovant (IMVT) United States $3.858B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.737B 0.00
NovoCure (NVCR) Jersey $3.615B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.395B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.365B 0.00
Denali Therapeutics (DNLI) United States $3.306B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.281B 0.00
Janux Therapeutics (JANX) United States $3.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.053B 0.00
Merus (MRUS) Netherlands $2.932B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.860B 0.00
SpringWorks Therapeutics (SWTX) United States $2.849B 0.00
Vericel (VCEL) United States $2.837B 957.83
Twist Bioscience (TWST) United States $2.819B 0.00
Amicus Therapeutics (FOLD) United States $2.797B 0.00
Vera Therapeutics (VERA) United States $2.789B 0.00
Kymera Therapeutics (KYMR) United States $2.729B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.719B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.716B 0.00
Edgewise Therapeutics (EWTX) United States $2.615B 0.00
Protagonist Therapeutics (PTGX) United States $2.448B 15.44
Iovance Biotherapeutics (IOVA) United States $2.386B 0.00
Geron (GERN) United States $2.333B 0.00
Beam Therapeutics (BEAM) United States $2.313B 0.00
NeoGenomics (NEO) United States $2.276B 0.00
Agios Pharmaceuticals (AGIO) United States $2.222B 0.00
Ligand Pharmaceuticals (LGND) United States $2.209B 55.15
IDEAYA Biosciences (IDYA) United States $2.177B 0.00
Bavarian Nordic (BVNRY) Denmark $2.155B 13.20
WAVE Life Sciences (WVE) Singapore $2.050B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.037B 0.00
Akero Therapeutics (AKRO) United States $2.016B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.007B 0.00
Apogee Therapeutics (APGE) United States $2.004B 0.00
ImmunityBio (IBRX) United States $2.000B 0.00
CG Oncology (CGON) United States $1.945B 0.00
Disc Medicine (IRON) United States $1.931B 0.00
Belite Bio (BLTE) United States $1.908B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.847B 15.35
Certara (CERT) United States $1.846B 52.14
MannKind (MNKD) United States $1.804B 46.71
Fortrea Holdings (FTRE) United States $1.794B 57.14
Structure Therapeutics (GPCR) United States $1.789B 0.00
Galapagos (GLPG) Belgium $1.767B 0.00
Dynavax Technologies (DVAX) United States $1.704B 99.69
Celldex Therapeutics (CLDX) United States $1.686B 0.00
Neumora Therapeutics (NMRA) United States $1.667B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.485B 0.00
Arcus Biosciences (RCUS) United States $1.472B 0.00
Novavax (NVAX) United States $1.459B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.458B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.446B 0.00
Nurix Therapeutics (NRIX) United States $1.436B 0.00
Viridian Therapeutics (VRDN) United States $1.414B 0.00
Travere Therapeutics (TVTX) United States $1.352B 0.00
MiMedx (MDXG) United States $1.346B 35.23
Mesoblast (MESO) Australia $1.343B 0.00
Arvinas (ARVN) United States $1.340B 0.00
Intellia Therapeutics (NTLA) United States $1.314B 0.00
Myriad Genetics (MYGN) United States $1.314B 0.00
Praxis Precision Medicines (PRAX) United States $1.308B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.286B 0.00
Spyre Therapeutics (SYRE) United States $1.241B 0.00
ANI Pharmaceuticals (ANIP) United States $1.190B 16.21
Syndax Pharmaceuticals (SNDX) United States $1.189B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.096B 0.00
Upstream Bio (UPB) United States $1.085B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Septerna (SEPN) United States $0.994B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.954B 0.00
Bicara Therapeutics (BCAX) United States $0.952B 0.00
Poseida Therapeutics (PSTX) United States $0.930B 0.00
Adaptive Biotechnologies (ADPT) United States $0.930B 0.00
Liquidia Technologies (LQDA) United States $0.924B 0.00
Pacira BioSciences (PCRX) United States $0.917B 8.63
Gyre Therapeutics (GYRE) United States $0.902B 0.00
ArriVent BioPharma (AVBP) United States $0.900B 0.00
Cogent Biosciences (COGT) United States $0.900B 0.00
Nuvation Bio (NUVB) United States $0.878B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
Immatics (IMTX) Germany $0.861B 0.00
Replimune (REPL) United States $0.859B 0.00
LENZ Therapeutics (LENZ) United States $0.852B 0.00
AbCellera Biologics (ABCL) Canada $0.830B 0.00
89BIO (ETNB) United States $0.816B 0.00
Pliant Therapeutics (PLRX) United States $0.809B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.35
Cytek Biosciences (CTKB) United States $0.800B 0.00
Avid Bioservices (CDMO) United States $0.789B 0.00
Immunome (IMNM) United States $0.785B 0.00
Keros Therapeutics (KROS) United States $0.763B 0.00
Tyra Biosciences (TYRA) United States $0.756B 0.00
UniQure (QURE) Netherlands $0.751B 0.00
Kura Oncology (KURA) United States $0.749B 0.00
GRAIL (GRAL) United States $0.745B 0.00
Erasca (ERAS) United States $0.724B 0.00
Anavex Life Sciences (AVXL) United States $0.717B 0.00
CureVac (CVAC) Germany $0.707B 5.75
Dianthus Therapeutics (DNTH) United States $0.705B 0.00
Oculis Holding AG (OCS) Switzerland $0.692B 0.00
Prothena (PRTA) Ireland $0.688B 0.00
Rapport Therapeutics (RAPP) United States $0.687B 0.00
Cullinan Therapeutics (CGEM) United States $0.684B 0.00
Tectonic Therapeutic (TECX) United States $0.669B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Entrada Therapeutics (TRDA) United States $0.661B 11.11
Arbutus Biopharma (ABUS) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.639B 0.00
MBX Biosciences (MBX) United States $0.633B 0.00
CARGO Therapeutics (CRGX) United States $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
Oric Pharmaceuticals (ORIC) United States $0.601B 0.00
Mineralys Therapeutics (MLYS) United States $0.592B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.580B 0.00
Terns Pharmaceuticals (TERN) United States $0.572B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.543B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.539B 0.00
Astria Therapeutics (ATXS) United States $0.537B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Humacyte (HUMA) United States $0.516B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.509B 0.00
CorMedix Inc (CRMD) United States $0.508B 0.00
Third Harmonic Bio (THRD) United States $0.507B 0.00
PureTech Health (PRTC) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.478B 0.00
Cartesian Therapeutics (RNAC) United States $0.475B 0.00
AnaptysBio (ANAB) United States $0.474B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.474B 0.00
Annexon (ANNX) United States $0.473B 0.00
ChromaDex (CDXC) United States $0.467B 612.00
Arcturus Therapeutics Holdings (ARCT) United States $0.466B 0.00
Celcuity (CELC) United States $0.465B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.464B 0.00
Emergent Biosolutions (EBS) United States $0.459B 0.00
MaxCyte (MXCT) United States $0.452B 0.00
Abivax SA (ABVX) France $0.450B 0.00
Codexis (CDXS) United States $0.450B 0.00
Kodiak Sciences (KOD) United States $0.446B 0.00
Alpha Teknova (TKNO) United States $0.428B 0.00
Sangamo Therapeutics (SGMO) United States $0.428B 0.00
IGM Biosciences (IGMS) United States $0.426B 0.00
Absci (ABSI) United States $0.424B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.422B 0.00
Sana Biotechnology (SANA) United States $0.422B 0.00
Aura Biosciences (AURA) United States $0.420B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
GH Research (GHRS) Ireland $0.403B 0.00
Allogene Therapeutics (ALLO) United States $0.396B 0.00
Alumis (ALMS) United States $0.396B 0.00
Olema Pharmaceuticals (OLMA) United States $0.387B 0.00
Northwest Biotherapeutics (NWBO) United States $0.385B 0.00
Prime Medicine (PRME) United States $0.378B 0.00
Zenas BioPharma (ZBIO) United States $0.373B 0.00
Contineum Therapeutics (CTNM) United States $0.362B 0.00
Neurogene (NGNE) United States $0.349B 0.00
Voyager Therapeutics (VYGR) United States $0.343B 8.83
Kamada (KMDA) Israel $0.337B 20.96
Sage Therapeutics (SAGE) United States $0.329B 0.00
Tango Therapeutics (TNGX) United States $0.329B 0.00
ACELYRIN, INC (SLRN) United States $0.324B 0.00
Revance Therapeutics (RVNC) United States $0.323B 0.00
Trevi Therapeutics (TRVI) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
Eton Pharmaceuticals (ETON) United States $0.319B 0.00
Prima BioMed (IMMP) Australia $0.317B 0.00
Design Therapeutics (DSGN) United States $0.317B 0.00
C4 Therapeutics (CCCC) United States $0.309B 0.00
Jasper Therapeutics (JSPR) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.295B 0.00
AC Immune (ACIU) Switzerland $0.292B 0.00
BioStem Technologies (BSEM) $0.286B 25.31
ITeos Therapeutics (ITOS) United States $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.280B 0.00
Renovaro (RENB) United States $0.279B 0.00
Benitec Biopharma (BNTC) United States $0.273B 0.00
EnGene Holdings (ENGN) Canada $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.269B 0.00
Urogen Pharma (URGN) United States $0.266B 0.00
Rezolute (RZLT) United States $0.266B 0.00
Mersana Therapeutics (MRSN) United States $0.266B 0.00
Chimerix (CMRX) United States $0.265B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.262B 0.00
Artiva Biotherapeutics (ARTV) United States $0.258B 0.00
ATyr Pharma (ATYR) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Anika Therapeutics (ANIK) United States $0.251B 0.00
Ocugen (OCGN) United States $0.250B 0.00
Atea Pharmaceuticals (AVIR) United States $0.247B 0.00
Nautilus Biotechnology (NAUT) United States $0.245B 0.00
Innate Pharma S.A (IPHA) France $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.231B 0.00
DiaMedica Therapeutics (DMAC) United States $0.230B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.220B 0.00
Candel Therapeutics (CADL) United States $0.219B 0.00
Molecular Partners AG (MOLN) Switzerland $0.219B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
XBiotech (XBIT) United States $0.212B 0.00
Inhibrx Biosciences (INBX) United States $0.212B 0.00
Gossamer Bio (GOSS) United States $0.211B 0.00
TuHURA Biosciences (HURA) United States $0.208B 0.00
Fate Therapeutics (FATE) United States $0.208B 0.00
Biomea Fusion (BMEA) United States $0.204B 0.00
Compass Therapeutics (CMPX) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.200B 0.00
Verastem (VSTM) United States $0.199B 0.00
Precigen (PGEN) United States $0.198B 0.00
Solid Biosciences (SLDB) United States $0.196B 0.00
Inozyme Pharma (INZY) United States $0.195B 0.00
Alector (ALEC) United States $0.193B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Kyverna Therapeutics (KYTX) United States $0.191B 0.00
Opthea (OPT) Australia $0.190B 0.00
Amarin (AMRN) Ireland $0.187B 0.00
Coherus BioSciences (CHRS) United States $0.185B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.179B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Semper Paratus Acquisition (TVGN) United States $0.175B 0.00
Sutro Biopharma (STRO) United States $0.175B 0.00
Climb Bio (CLYM) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.173B 0.00
2seventy Bio (TSVT) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Adherex Technologies (FENC) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.161B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
ScPharmaceuticals (SCPH) United States $0.160B 0.00
CAMP4 Therapeutics (CAMP) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.153B 0.00
PepGen (PEPG) United States $0.153B 0.00
TScan Therapeutics (TCRX) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.150B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Seer (SEER) United States $0.146B 0.00
Black Diamond Therapeutics (BDTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.144B 80.50
Instil Bio (TIL) United States $0.143B 0.00
Elutia (ELUT) United States $0.143B 0.00
Puma Biotechnology (PBYI) United States $0.141B 6.00
InflaRx (IFRX) Germany $0.139B 0.00
Cabaletta Bio (CABA) United States $0.138B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
Applied Therapeutics (APLT) United States $0.134B 0.00
Inventiva S.A (IVA) France $0.129B 0.00
Aligos Therapeutics (ALGS) United States $0.122B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.122B 0.00
Editas Medicine (EDIT) United States $0.119B 0.00
X4 Pharmaceuticals (XFOR) United States $0.114B 0.00
Leap Therapeutics (LPTX) United States $0.113B 0.00
Akoya Biosciences (AKYA) United States $0.113B 0.00
Adverum Biotechnologies (ADVM) United States $0.112B 0.00
TELA Bio (TELA) United States $0.109B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Alto Neuroscience (ANRO) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Skye Bioscience (SKYE) United States $0.103B 0.00
Immunic (IMUX) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Scilex Holding (SCLX) United States $0.097B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
Rani Therapeutics Holdings (RANI) United States $0.095B 0.00
Invizyne Technologies (IZTC) United States $0.095B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.094B 0.00
Genenta Science S.p.A (GNTA) Italy $0.094B 0.00
Allakos (ALLK) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.089B 0.00
23andMe Holding (ME) United States $0.088B 0.00
CytomX Therapeutics (CTMX) United States $0.087B 6.53
Adlai Nortye (ANL) Cayman Islands $0.085B 0.00
I-Mab (IMAB) China $0.082B 0.00
Vigil Neuroscience (VIGL) United States $0.081B 0.00
Genelux (GNLX) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Abpro Holdings (ABP) United States $0.079B 0.00
Generation Bio (GBIO) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
FibroBiologics (FBLG) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
Repare Therapeutics (RPTX) Canada $0.075B 0.00
Werewolf Therapeutics (HOWL) United States $0.074B 0.00
DBV Technologies S.A (DBVT) France $0.073B 0.00
Annovis Bio (ANVS) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Agenus (AGEN) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.070B 0.00
BioAtla (BCAB) United States $0.070B 0.00
Theratechnologies (THTX) Canada $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.069B 0.00
PDS Biotechnology (PDSB) United States $0.069B 0.00
Vor Biopharma (VOR) $0.068B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Invivyd (IVVD) United States $0.065B 0.00
BeyondSpring (BYSI) United States $0.064B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Galena Biopharma (SLS) United States $0.061B 0.00
Inovio Pharmaceuticals (INO) United States $0.061B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.060B 0.00
Aadi Bioscience (AADI) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Spero Therapeutics (SPRO) United States $0.058B 15.29
Immix Biopharma (IMMX) United States $0.056B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.056B 0.00
Boundless Bio (BOLD) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Omega Therapeutics (OMGA) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
IO Biotech (IOBT) Denmark $0.053B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.051B 0.00
Immuneering (IMRX) United States $0.051B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Celularity (CELU) United States $0.049B 0.00
Dyadic (DYAI) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Passage Bio (PASG) United States $0.047B 0.00
Exicure (XCUR) United States $0.045B 0.00
Q32 Bio (QTTB) United States $0.045B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
AN2 Therapeutics (ANTX) United States $0.043B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.042B 0.00
Precision BioSciences (DTIL) United States $0.042B 0.00
Clene (CLNN) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
SAB Biotherapeutics (SABS) United States $0.038B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.036B 0.00
Grace Therapeutics (GRCE) Canada $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Affimed (AFMD) Germany $0.035B 0.00
Forte Biosciences (FBRX) United States $0.034B 0.00
Beyond Air (XAIR) United States $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Alpha Cognition (ACOG) Canada $0.033B 0.00
Opus Genetics (IRD) United States $0.032B 0.00
Rapt Therapeutics (RAPT) United States $0.032B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
NextCure (NXTC) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Senti Biosciences (SNTI) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
MiNK Therapeutics (INKT) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
IN8bio (INAB) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MetaVia (MTVA) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Imunon (IMNN) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
CervoMed (CRVO) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Apollomics (APLM) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Evaxion Biotech (EVAX) Denmark $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Carmell (CTCX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Palisade Bio (PALI) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00